Target intelligence / Profile preview

Formin homology 2 domain (FH2)

Target
FH2
Molecular classification
Actin-binding protein, Cytoskeletal protein, Protein domain, Actin nucleator
01

Overview

The Formin Homology 2 (FH2) domain is a highly conserved protein structural motif found in the formin family of proteins, which are key regulators of the actin and microtubule cytoskeleton [6, 10]. Functioning as a homodimer, the FH2 domain forms a characteristic donut-shaped structure that nucleates new actin filaments and processively tracks the growing barbed ends, protecting them from capping proteins while allowing for rapid elongation [8, 11]. Because formins are essential for fundamental cellular processes such as cytokinesis, cell migration, and morphogenesis, the FH2 domain has emerged as a potential therapeutic target for diseases characterized by aberrant cytoskeletal dynamics, including cancer metastasis and various genetic disorders [7, 16]. Small molecule inhibitors like SMIFH2 have been developed to block the FH2 domain activity, providing valuable tools for research and a starting point for drug discovery [1, 4]. However, achieving isoform specificity among the 15 human formins and avoiding off-target effects on other cytoskeletal proteins like myosins remain significant challenges in the development of formin-targeted therapies [1, 13].

Other names
FH2 domainFormin homology domain 2
02

Mechanism of action

Inhibition of actin nucleation and elongation by binding to the FH2 domain and preventing its interaction with actin monomers and filaments.

03

Biological functions

Actin nucleationActin polymerizationCytoskeleton organizationCell motilityCytokinesisMicrotubule stabilizationProcessive capping
04

Disease associations

CancerSensorineural hearing lossNeurodegenerative diseaseCardiovascular diseaseRenal diseasePeripheral neuropathyThrombocytopenia
05

Safety considerations

Off-target effects on myosinsCytoskeletal toxicityLack of isoform specificity among the 15 human formins
06

Interacting drugs

SMIFH2

1 more in the full profile.

07

Biomarkers

F-actin levelsCell migration rateDIAPH1 mutation statusTubulin acetylation status

Beyond the preview

Go deeper on Formin homology 2 domain (FH2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Formin homology 2 domain (FH2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call